基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
无可用的信号评分。
Browse the full record of transactions filed by Barton Shane, VP et Contrôleur Corporatif. Insider active across 2 companies, notably Precision Biosciences INC. Cumulatively, 15 disclosures have been published. Split: 1 buy · 2 sells. Total volume traded: €42k. Activity tracked since 26 February 2021. The latest transaction was filed on 27 September 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 条申报中的 15 条
Barton Shane is VP et Contrôleur Corporatif. He has 15 filings in total, and among the sampled recent filings the most common transaction nature is Levée d'options, with buys totaling EUR 42386 and no sells reported, over the period from 2022-03-07 to 2026-07-01. His recent filings concern BioAge Labs, Inc. and Precision Biosciences INC.